© 1997 by Biometrika Trust
A consistent estimator for the distribution of quality adjusted survival time
Department of Biostatistics, Harvard School of Public Health Boston, Massachusetts 02115, U.S.A. e-mail: zhao{at}hsph.harvard.edu
Department of Statistics, North Carolina State University Raleigh, North Carolina 27695, U.S.A. e-mail: tsiatis{at}stat.ncsu.edu
Quality adjusted survival analysis is a new approach to therapy evaluation in clinical trials. It has received much attention recently because of its ability to take patients' quality of life into consideration. In this paper, we present a method that enables us to calculate the survival distribution of quality adjusted lifetime. Using martingale theory for counting processes, we can show that our estimator is asymptotically consistent, normally distributed, and its asymptotic variance estimate can be obtained analytically. Simulation experiments are conducted to compare our estimator with the true underlying distribution for two cases that are of practical importance.
Key Words: Counting process Martingale process Quality of life Survival analysis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Wang and H. Zhao Regression analysis of mean quality-adjusted lifetime with censored data Biostat., April 1, 2007; 8(2): 368 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A R Willan, D Y Lin, R J Cook, and E B Chen Using inverse-weighting in cost-effectiveness analysis with censored data Statistical Methods in Medical Research, December 1, 2002; 11(6): 539 - 551. [Abstract] [PDF] |
||||
![]() |
P. F Thall Ethical issues in oncology biostatistics Statistical Methods in Medical Research, October 1, 2002; 11(5): 429 - 448. [Abstract] [PDF] |
||||
![]() |
R J Cook and J F Lawless Analysis of repeated events Statistical Methods in Medical Research, April 1, 2002; 11(2): 141 - 166. [Abstract] [PDF] |
||||
![]() |
M. S. Pepe, R. Etzioni, Z. Feng, J. D. Potter, M. L. Thompson, M. Thornquist, M. Winget, and Y. Yasui Phases of Biomarker Development for Early Detection of Cancer J Natl Cancer Inst, July 18, 2001; 93(14): 1054 - 1061. [Full Text] [PDF] |
||||


